ENEV3:BMFBOVESPAEneva S.A. Analysis

Eneva (ENEV3) is trading at R$20.04, just above the technical support of R$19.76 and well below the resistance at R$22.55, with the 20‑day SMA (R$21.12) and 50‑day SMA (R$21.05) hovering near current levels. The 200‑day SMA (R$17.35) lies comfortably below, confirming a bullish trend despite a bearish MACD histogram and a neutral RSI of 42, while volume is on a decreasing path. Volatility is high at 50.8% over 30 days, but the beta of 0.37 suggests the stock moves less than the market, tempering systematic risk. On the fundamentals side, revenue surged 24.5% YoY to R$18.4 bn, yet free cash flow remains negative and debt‑to‑equity is elevated at 110.7, highlighting balance‑sheet pressure. The DCF‑derived fair value of R$57.68 implies a 22% upside from the current price, and the forward PE of 15.96 contrasts sharply with the trailing PE of 33.4, which is above the industry average of 23.25. Analysts collectively rate the stock as a strong buy with a median target near R$25, reflecting confidence in growth prospects despite the capital‑structure concerns.
Overall, the combination of a supportive technical backdrop, strong top‑line growth, and a sizeable valuation gap positions ENEV3 as an attractive entry point for investors willing to navigate short‑term liquidity constraints and debt‑related risks, while the sector’s defensive nature and low beta provide a cushion against broader market volatility.